CLINICAL_TRIALS
trial_result
· 2019-09-06
Clinical Trial Update: Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Accelerated Phase (AP) [Phase 2]
Summary
Phase 2 trial evaluating ponatinib as frontline therapy for chronic myeloid leukemia in accelerated phase; the study was terminated and results were posted in 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2019-09-06